# Northwest Biotherapeutics Inc: Form 8-K, filed Mar 8, 2023

- Company: [Northwest Biotherapeutics Inc](/companies/nwbo.md) (CIK 1072379)
- Form: 8-K
- Filed: 2023-03-08
- Accepted by EDGAR: Mar 8, 2023, 16:56 ET
- Period: 2023-03-02
- Accession: 0001104659-23-030141
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1072379/000110465923030141/tm238973_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1072379/000110465923030141/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1072379/000110465923030141/tm238973_8k.htm

Filed Mar 8, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-030141. Last ingested by Listed: Oct 30, 2026, 16:18 ET. No prices; not investment advice.